Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carboplatin/Paclitaxel vs TAP in Advanced Endometrial Cancer
NCT00063999Phase 3Completed
- Sponsor
- GOG Foundation
- Start
- Aug 2003
- Primary completion
- Jun 2013
- Modality
- DNA Intercalators/Alkylators
- Countries
- 3
01
Overview
Phase 3, randomised, open-label trial of carboplatin in endometrial cancer (EC) (2 arms), sponsored by GOG Foundation. Primary endpoint: Overall Survival at 10 years. Started Aug 2003; status: completed.
02
Drugs
carboplatin
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on NCT00063999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00063999.